Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3392132rdf:typepubmed:Citationlld:pubmed
pubmed-article:3392132lifeskim:mentionsumls-concept:C0549473lld:lifeskim
pubmed-article:3392132lifeskim:mentionsumls-concept:C1522577lld:lifeskim
pubmed-article:3392132lifeskim:mentionsumls-concept:C0439234lld:lifeskim
pubmed-article:3392132pubmed:issue4lld:pubmed
pubmed-article:3392132pubmed:dateCreated1988-8-18lld:pubmed
pubmed-article:3392132pubmed:abstractTextOutcome in 190 patients operated upon by first intention for thyroid cancer is analyzed after follow up over more than 5 years. No deaths due to cancer occurred in 57 cases of papillary cancer, but 7 cases presented pulmonary metastases, while the global-5-year survival rate in 63 cases of vesicular cancer (including 25% with preoperative metastases) was 60%. In the absence of preoperative metastases, ans if well differentiated forms are separated from moderately differentiated forms, the respective 5-year survivals were 88 and 45%. The 1-year survival rate for the 42 cases of anaplastic cancer was 15%, while the 5-year rate for 15 cases of medullary cancer was 80%.lld:pubmed
pubmed-article:3392132pubmed:languagefrelld:pubmed
pubmed-article:3392132pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3392132pubmed:citationSubsetIMlld:pubmed
pubmed-article:3392132pubmed:statusMEDLINElld:pubmed
pubmed-article:3392132pubmed:monthAprlld:pubmed
pubmed-article:3392132pubmed:issn0021-7697lld:pubmed
pubmed-article:3392132pubmed:authorpubmed-author:MethlinGGlld:pubmed
pubmed-article:3392132pubmed:authorpubmed-author:MoysesBBlld:pubmed
pubmed-article:3392132pubmed:authorpubmed-author:GrobJ CJClld:pubmed
pubmed-article:3392132pubmed:authorpubmed-author:PuselJJlld:pubmed
pubmed-article:3392132pubmed:authorpubmed-author:RodierDDlld:pubmed
pubmed-article:3392132pubmed:authorpubmed-author:JanserJ CJClld:pubmed
pubmed-article:3392132pubmed:authorpubmed-author:RodierJ FJFlld:pubmed
pubmed-article:3392132pubmed:authorpubmed-author:NavarreteHHlld:pubmed
pubmed-article:3392132pubmed:issnTypePrintlld:pubmed
pubmed-article:3392132pubmed:volume125lld:pubmed
pubmed-article:3392132pubmed:ownerNLMlld:pubmed
pubmed-article:3392132pubmed:authorsCompleteYlld:pubmed
pubmed-article:3392132pubmed:pagination249-54lld:pubmed
pubmed-article:3392132pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:3392132pubmed:meshHeadingpubmed-meshheading:3392132-...lld:pubmed
pubmed-article:3392132pubmed:meshHeadingpubmed-meshheading:3392132-...lld:pubmed
pubmed-article:3392132pubmed:meshHeadingpubmed-meshheading:3392132-...lld:pubmed
pubmed-article:3392132pubmed:meshHeadingpubmed-meshheading:3392132-...lld:pubmed
pubmed-article:3392132pubmed:meshHeadingpubmed-meshheading:3392132-...lld:pubmed
pubmed-article:3392132pubmed:meshHeadingpubmed-meshheading:3392132-...lld:pubmed
pubmed-article:3392132pubmed:meshHeadingpubmed-meshheading:3392132-...lld:pubmed
pubmed-article:3392132pubmed:meshHeadingpubmed-meshheading:3392132-...lld:pubmed
pubmed-article:3392132pubmed:meshHeadingpubmed-meshheading:3392132-...lld:pubmed
pubmed-article:3392132pubmed:meshHeadingpubmed-meshheading:3392132-...lld:pubmed
pubmed-article:3392132pubmed:meshHeadingpubmed-meshheading:3392132-...lld:pubmed
pubmed-article:3392132pubmed:meshHeadingpubmed-meshheading:3392132-...lld:pubmed
pubmed-article:3392132pubmed:meshHeadingpubmed-meshheading:3392132-...lld:pubmed
pubmed-article:3392132pubmed:year1988lld:pubmed
pubmed-article:3392132pubmed:articleTitle[190 cancers of the thyroid with a follow-up of more than 5 years].lld:pubmed
pubmed-article:3392132pubmed:affiliationDépartement de Chirurgie cancérologique, Centre Paul Strauss, Strasbourg.lld:pubmed
pubmed-article:3392132pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3392132pubmed:publicationTypeEnglish Abstractlld:pubmed